Product Information
OLOPATADINE HCL 0.1% EYE DROP is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.2228 per ML under NDC 16571088205. Its NADAC has been published 44 times since Aug 27, 2025.
Strength
1 mg/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
16571088205
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204392On Market Since
5/1/2025
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.1% EYE DROP has been published 44 times since Aug 27, 2025, and over the history we have for it it has declined 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2228 per ML |
|---|---|
| All-time high | $1.3149 (Sep 10, 2025) |
| All-time low | $1.2029 (Feb 18, 2026) |
| 52-week high | $1.3149 |
| 52-week low | $1.2029 |
| Median price | $1.2228 |
| Average price | $1.2394 |
| Largest weekly change | -3.1% (Sep 17, 2025) |
| Weeks tracked | 44 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.1% EYE DROP, manufactured by Rising Pharma Holdings Inc., is $1.2228 per ML (NDC 16571088205), effective Jun 24, 2026.
How has the price of OLOPATADINE HCL 0.1% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has declined 7.0%. It has been tracked across 44 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.1% EYE DROP?
Since Aug 27, 2025, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has ranged from a low of $1.2029 (Feb 18, 2026) to a high of $1.3149 (Sep 10, 2025), with a median of $1.2228 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.1% EYE DROP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OLOPATADINE HCL 0.1% EYE DROP, but none are currently priced below it.
Who manufactures OLOPATADINE HCL 0.1% EYE DROP?
OLOPATADINE HCL 0.1% EYE DROP (NDC 16571088205) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification